Molecular biology. Cancer fighter's modus operandi revealed
- PMID: 11012350
- DOI: 10.1126/science.289.5486.1857
Molecular biology. Cancer fighter's modus operandi revealed
Abstract
Researchers have deciphered how a promising cancer drug acts like a smart bomb, homing in on only a very narrow range of its potential targets in the cell. The compound, known as STI-571, has shown remarkable success in early clinical trials on patients with chronic myelogenous leukemia. Now, in work reported on page 1938, scientists reveal just how the compound works--information that could aid in the design of similar cancer therapies.
Comment on
-
Structural mechanism for STI-571 inhibition of abelson tyrosine kinase.Science. 2000 Sep 15;289(5486):1938-42. doi: 10.1126/science.289.5486.1938. Science. 2000. PMID: 10988075
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical